at-home diagnostics

The home diagnostics company also cut 170 manufacturing jobs in the summer.

LetsGetChecked, which closed a $150 million Series D funding round in 2021, made multiple acquisitions this year.

The collection by Getlabs will cost users a convenience fee starting at $25.

Cue received emergency use authorization for its at-home COVID-19 test in March and went public in September.

Its Bisu Body Coach provides personalised health advice through urine and saliva testing.

The new acquistiion is expected to help the company grow out its diagnostic capabilities.

Lucira's molecular testing kit allows individuals to collect their own nasal sample and insert it into a device that provides results in under 30 minutes. The company is aiming to sell the single-use tests for roughly $50.

Nurx, Carbon Health and Everlywell have officially halted their mail-order testing-kit services. But at least one startup is still moving to secure an Emergency Use Authorization for its at-home rapid serology diagnostic.